Clinical Trial: Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer

Sponsor and Collaborators
Cancer and Leukemia Group B
National Cancer Institute (NCI)

Principal Investigator
Study Chair: Ghassan Abou-Alfa, MD Memorial Sloan-Kettering Cancer Center


Continue Reading

ClinicalTrials.gov Identifier
NCT01015833